UK charity pockets $150 million from Merck cancer immu**therapy drug
 

UK charity pockets $150 million from Merck cancer immu**therapy drug
LONDON (Reuters) - British medical charity MRC Tech**logy has pocketed $150 million by selling part of its royalty interest in Merck & Co's successful cancer drug Keytruda, allowing it to plough fresh funds into new research.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...8A:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...8A:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/XwbtDuW7dSg